1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 3: Bayesian-derived quantitative analysis of CBF, CBV, and MTT for gray matter and white matter in half-dose (0.05-mmol/kg) and full-dose (0.1-mmol/kg) contrast groupsa
Contrast Dose Bayesian-Processed DSC GM t Test (P Value) WM t Test (P Value) FD HD FD HD CBF (mL/100 g/min) 75.7 ± 27.0 62.1 ± 23.2 .001b 21.6 ± 7.1 17.9 ± 6.2 .037b CBV (mL/100 g) 2.2 ± 0.8 1.8 ± 0.7 .090 1.3 ± 0.4 1.1 ± 0.4 .11 MTT (sec) 2.9 ± 0.9 2.7 ± 1.1 .450 4.3 ± 1.1 4.8 ± 1.2 .051